Showing results (821-830 of 835) with videos related to

Sort By:
Pageof 84
Blood Advances|May 26, 2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host diseaseMonzr M Al Malki, Kaitlyn London, Janna Baez, et al.
Blood Advances|June 14, 2023
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHDYu Akahoshi, Nikolaos Spyrou, William J Hogan, et al.
Transplantation and Cellular Therapy|February 6, 2024
A Day 14 Endpoint for Acute GVHD Clinical TrialsNikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, et al.
Nature Medicine|April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.
Blood Advances|December 10, 2019
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host diseaseHrishikesh K Srinagesh, Umut Özbek, Urvi Kapoor, et al.
The Journal of Clinical Investigation|July 31, 2020
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2Caroline Diorio, Sarah E Henrickson, Laura A Vella, et al.
Bone Marrow Transplantation|February 20, 2013
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experienceG A Hale, M Arora, K W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2018
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow TransplantationAnkit J Kansagra, Noelle V Frey, Merav Bar, et al.
Science Advances|November 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell functionAlexander J Dimitri, Amy E Baxter, Gregory M Chen, et al.
Pageof 84